4/23
11:51 am
spro
Spero Therapeutics Delivers On Game Plan To Create Shareholder Value [Seeking Alpha]
Low
Report
Spero Therapeutics Delivers On Game Plan To Create Shareholder Value [Seeking Alpha]
4/4
10:09 am
spro
Spero Therapeutics, Inc. (NASDAQ: SPRO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Spero Therapeutics, Inc. (NASDAQ: SPRO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
3/18
02:52 pm
spro
Spero Therapeutics, Inc. (NASDAQ: SPRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
Spero Therapeutics, Inc. (NASDAQ: SPRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
3/17
09:27 am
spro
Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year [Yahoo! Finance]
Low
Report
Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year [Yahoo! Finance]
3/15
01:02 pm
spro
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/15
07:16 am
spro
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market? [Yahoo! Finance]
Medium
Report
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market? [Yahoo! Finance]
3/14
09:31 am
spro
Thinking about buying stock in CXApp, CCSC Technology International, Vroom, Spero Therapeutics, or OptiNose?
Medium
Report
Thinking about buying stock in CXApp, CCSC Technology International, Vroom, Spero Therapeutics, or OptiNose?
3/13
04:21 pm
spro
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update [Yahoo! Finance]
Low
Report
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update [Yahoo! Finance]
3/13
04:01 pm
spro
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
Medium
Report
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
3/6
08:05 am
spro
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
Medium
Report
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
2/28
08:05 am
spro
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
Low
Report
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
2/26
08:18 am
spro
Spero Therapeutics to Present at Cowen's 44th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
Spero Therapeutics to Present at Cowen's 44th Annual Healthcare Conference [Yahoo! Finance]
2/26
08:05 am
spro
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
Low
Report
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
2/5
11:46 pm
spro
Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares [Yahoo! Finance]
Low
Report
Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares [Yahoo! Finance]
1/31
04:05 pm
spro
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)